A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations
Authors:
- H. NauHNH. Nau
- R. ZiererRZR. Zierer
- H. SpielmannHSH. Spielmann
- D. NeubertDND. Neubert
- Ch. GansauCGCh. Gansau
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 29 (26) , 2803-2813
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Drug delivery systemsPharmacology & Therapeutics, 1981
- Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography—mass spectrometry using selected ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The osmotic pump: novel research tool for optimizing drug regimensBiomaterials, 1981
- Valproic acid dosage and plasma protein binding and clearanceClinical Pharmacology & Therapeutics, 1980
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Valproic AcidArchives of Neurology, 1979
- Determination of valproic acid (DI-N-propyl acetic acid) in plasma by gas-liquid chromatography with pre-column butylationClinica Chimica Acta, 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979